Archive for March, 2010

The British Heart Foundation Welcomes New Draft NICE Guidance On Dronedarone

Wednesday, March 31st, 2010
In response to new draft NICE guidance published today, recommending limited use of dronedarone for atrial fibrillation (AF), June Davison, Senior Cardiac Nurse at the British Heart Foundation (BHF) said: "The BHF welcomes the new draft guidance published today by NICE. This demonstrates that the committee took on board feedback from the consultation earlier this year, including from organisations such as ours...


Agency For Healthcare Research And Quality Takes To The Airwaves To Communicate Vital Health Care Information To Spanish Speakers

Wednesday, March 31st, 2010
HHS' Agency for Healthcare Research and Quality announced Healthcare 411 en Español - a new audio news series to provide Spanish speakers with evidence-based consumer information to help them stay healthy, prevent diseases, compare the effectiveness of various medical treatments, and obtain high-quality and safe health care. Under this new initiative, AHRQ is producing two 60-second audio reports each month and distributing them to Spanish-language radio stations nationwide...


Clinical Study Published Regarding Plasma Disc Decompression For The Treatment Of Low Back Pain Associated With Contained Herniated Discs

Wednesday, March 31st, 2010
ArthroCare Corp. (NASDAQ: ARTC), a leader in developing state-of-the-art, minimally invasive surgical products, announced today the publication of an important clinical trial demonstrating that patients treated with ArthroCare's Plasma Disc Decompression (PDD) products experienced reduced pain and better quality of life scores compared to patients treated with the current standard care, epidural steroid injections...


Clinical Data, Inc. Reports Results Of Phase I Studies Of Stedivaze™ Demonstrating Safety And Tolerability In Patients With Asthma And COPD

Wednesday, March 31st, 2010
Clinical Data, Inc. (NASDAQ: CLDA), announced results from two Phase I studies of Stedivaze™ (apadenoson), which demonstrated that Stedivaze was safe and well tolerated in patients with asthma and chronic obstructive pulmonary disease (COPD). Stedivaze is a potent and highly selective agonist of the adenosine A2A receptor subtype in development as a pharmacologic stress agent for myocardial perfusion imaging (MPI). Currently available adenosine agonists must be used with caution or are contraindicated in patients with asthma and COPD...


Alaska Northern Lights Offers Bright Light Therapy To Combat Common Health Problems

Wednesday, March 31st, 2010
Alaska Northern Lights manufactures a bright light therapy box that aids in treating chronic health problems such as seasonal affective disorder (SAD), depression, bipolar disorder and sleep problems. Sufferers of SAD, a form of clinical depression, include up to 25 percent of those living in northern latitudes who experience varying degrees of SAD during winter months when there is less natural light. Night shift workers are also susceptible to SAD which affects over one third of the population, or about 10.8 million Americans...


NMS Labs Launches Pain Management Lab Test For Milnacipran, A New Drug Approved By The FDA For The Treatment Of Fibromyalgia Pain

Wednesday, March 31st, 2010
NMS Labs launches another unique test suitable for the evaluation of toxicity vs. efficacy, the potential for physicians to establish therapeutic drug monitoring (TDM) of individual patients, and the assessment of drug diversion of a new pain management drug therapy. NMS Labs is the only known commercial laboratory to develop and perform a clinical quantitative assay for Milnacipran (Savella®) using the highly specific and sensitive technique of liquid chromatography/tandem mass spectrometry (LC-MS/MS)...


What Every Woman Should Know About Endometriosis: Surprising Truths And Best Treatment Options

Wednesday, March 31st, 2010
One out of every two women struggling to conceive may suffer from endometriosis - the leading cause of infertility - according to researchi from Camran Nezhat, M.D., gynecologist at El Camino Hospital, the hospital of the Silicon Valley. Almost 5.5 millionii women in the U.S. suffer from the often painful symptoms of the condition, a disease characterized by endometrium, or tissue, which normally lines the uterus, growing in other places. Yet, Dr...


Policy On The Run Will Disadvantage People With Diabetes, Australia

Wednesday, March 31st, 2010
AMA President, Dr Andrew Pesce, said today that the Government's proposed voluntary enrolment plan for people with diabetes is policy on the run that will make it more difficult for patients to access vital GP services. Dr Pesce said the AMA appreciates that the Government wants to address the special care needs of people with complex and chronic conditions, but today's rushed policy is an announcement for Premiers, not patients...


PolyMedix Successfully Completes Phase 1B Clinical Study With Novel Antibiotic PMX-30063

Wednesday, March 31st, 2010
PolyMedix, Inc. (OTC BB: PYMX), an emerging bio-technology company focused on developing new therapeutic drugs to treat acute cardiovascular disorders and infectious diseases, has successfully completed a Phase 1B clinical study with its novel defensin-mimetic antibiotic, PMX-30063. The data from the study demonstrate that administration of multiple doses of PMX-30063 are safe and well-tolerated at dose levels which showed bactericidal activity in blood samples drawn from subjects in the study...


Secretary Sebelius Awards Funding For Chronic Disease Self-Management Programs For Older Americans

Wednesday, March 31st, 2010
Older Americans with chronic diseases can learn how to manage their conditions and take control of their health using the $27 million in grants announced today by the U.S. Department of Health and Human Services Secretary Kathleen Sebelius...